Differential Roles of MAPK-Erk1/2 and MAPK-p38 in Insulin or Insulin-Like Growth Factor-I (IGF-I) Signaling Pathways for Progesterone Production in Human Ovarian Cells

Abstract

Insulin and insulin like-growth factor-I (IGF-I) participate in the regulation of ovarian steroidogenesis. In insulin resistant states ovaries remain sensitive to insulin because insulin can activate alternative signaling pathways, such as phosphatidylinositol-3-kinase (PI-3 kinase) and mitogen-activated protein-kinase (MAPK) pathways, as well as insulin receptors and type 1 IGF receptors. We investigated the roles of MAPK-Erk1/2 and MAPK-p38 in insulin and IGF-I signaling pathways for progesterone production in human ovarian cells. Human ovarian cells were cultured in tissue culture medium in the presence of varying concentrations of insulin or IGF-I, with or without PD98059, a specific MAPK-Erk1/2 inhibitor, with or without SB203580, a specific MAPK-p38 inhibitor or with or without a specific PI-3-kinase inhibitor LY294002. Progesterone concentrations were measured using radioimmunoassay. PD98059 alone stimulated progesterone production in a dose-dependent manner by up to 65% (p<0.001). Similarly, LY294002 alone stimulated progesterone production by 13–18% (p<0.005). However, when used together, PD98059 and LY294002 inhibited progesterone production by 17–20% (p<0.001). SB203580 alone inhibited progesterone production by 20–30% (p<0.001). Insulin or IGF-I alone stimulated progesterone production by 40–60% (p<0.001). In insulin studies, PD98059 had no significant effect on progesterone synthesis while SB203580 abolished insulin-induced progesterone production. Either PD98059 or SB203580 abolished IGF-I-induced progesterone production. Both MAPK-Erk1/2 and MAPK-p38 participate in IGF-I-induced signaling pathways for progesterone production, while insulin-induced progesterone production requires MAPK-p38, but not MAPK-Erk1/2. These studies provide further evidence for divergence of insulin and IGF-I signaling pathways for human ovarian cell steroidogenesis.

insulin - IGF-1 - steroid hormones - mitogen activated protein kinase - progesterone synthesis - polycystic ovary syndrome

References

• 1 Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states.  Endocr Rev. 1991;  12 3-13
• 2 Bothero LF, Robert CT, LeRoith D, Adashi EY, Henandez ER. Insulin-like growth factor I gene expression by primary culture of ovarian cells: insulin and dexamethansone dependence.  Endocrinology. 1993;  132 2703-2708
• 3 Willis D, Franks S. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor.  J Clin Endocrinol Metab. 1995;  8 3788-3790
• 4 Tajima K, Yoshii K, Fukuda S, Orisaka M, Miyamoto K, Amsterdam A, Kotsuji F. Luteinizing hormone-induced extracellular-signal regulated kinase activation differently modulates progesterone and androstenedione production in bovine theca cells.  Endocrinology. 2005;  146 2903-2910
• 5 Dewi DA, Abayasekara DRE, Wheeler-Jones CPD. Requirement for Erk1/2 activation in the regulation of progesterone production in human granulosa-lutein cells is stimulus specific.  Endocrinology. 2002;  143 877-888
• 6 Tajima K, Zhong D, Yao Z, Sorokina K, Kotsuji F, Seger R, Amsterdam A. Down-regulation of steroidogenic response to gonadotropins in human and rat preovulatory granulosa cells involves mitogen-activated protein kinase activation and modulation of DAX-1 and steroidogenic factor-1.  J Clin Endocrinol Metab. 2003;  88 2288-2299
• 7 Lin Q, Poon SL, Chen J, Cheng L, HoYuen B, Leung PCK. Leptin interferes with 3′,5′-cyclic adenosine monophosphate (cAMP) signaling to inhibit steroidogenesis in human granulosa cells.  Reprod Biol Endocrinol. 2009;  7 115-123
• 8 Yu FQ, Han CS, Yang W, Jin X, Hu ZY, Liu Y-X. Activation of the p38 MAPK pathway by follicle-stimulating hormone regulates steroidogenesis in granulosa cells differentially.  J Endocrinology. 2005;  186 85-96
• 9 Poretsky L, Seto-Young D, Shrestha A, Dhillon S, Mirjany N, Liu H-C, Yih MC, Rosenwaks Z. Phosphatidyl-inositol-3 kinase-independent insulin action pathway(s) in the human ovary.  J Clin Endocrinol Metab. 2001;  86 3115-3119
• 10 Seto-Young D, Leonardi O, Park A, Holcomb K, Salehi M, Chang P, Yih Melissa, Rosenwaks Z, Poretsky L. Hormonally active non-transformed human ovarian cell culture from oophorectomy specimens: methods of development and initial characterization.  Horm Res. 2005;  64 238-247
• 11 Seto-Young D, Paliou M, Schlosser J, Avtanski D, Park A, Patel P, Holcomb K, Chang P, Poretsky L. Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production.  J Clin Endocrinol Metab. 2005;  90 6099-6105
• 12 Seto-Young D, Zajac J, Liu H-C, Rosenwaks Z, Poretsky L. The Role of Mitogen activated protein kinase (MAPK) in Insulin and IGF-I Signaling Cascades for Progesterone and IGFBP-1 Production in Human Granulosa Cells granulosa cells.  J Clin Endocrinol Metab. 2003;  88 3385-3391
• 13 Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease.  Endocr Rev. 1999;  20 535-582

Correspondence